Locations:

Cancer

February 11, 2019/Cancer/News & Insight

Risk of Epstein-Barr-Associated Post-Transplant Lymphoproliferative Disorders Low in Solid Organ Transplant Patients

Liver and intestine recipients at greater risk

February 7, 2019/Cancer/Research

Therapeutic Target Identified for Small Cell Bladder Cancer

Gene expression analysis uncovers clues

February 6, 2019/Cancer/News & Insight

Chipping Away at the Mystery of Clonal Hematopoiesis of Indeterminate Potential (CHIP)

CHIP clinic in the works

February 4, 2019/Cancer/News & Insight

Electronic Brachytherapy: Is It a Viable Option?

Why experts advise against it for breast, skin and gynecologic cancers

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

January 30, 2019/Cancer/Research

Survival Rates Higher for Patients with Metastatic Renal Cancer at High-Volume Facilities

Study first to compare rates for mRCC medical oncology

January 28, 2019/Cancer/Research

New Treatment Regimen Holds Promise for Patients with Mantle Cell Lymphoma

Novel drugs included in therapy

January 25, 2019/Cancer

From Pharmacist to Dermatologist: Never Be Afraid to Reinvent Yourself

A Q&A with Allison Vidimos, RPh, MD

January 24, 2019/Cancer/Blood Cancers

Additions to R-CHOP in Patients with Diffuse or Aggressive Large B-Cell Lymphoma

Genetics affect how patients respond

18-RHE-10377-Calabrese-Hero-Image-650x450pxl

January 22, 2019/Cancer

A Novel Tumor Board for Patients with Immune-Related Adverse Events

Collaborating to treat this emerging complication of CPI

January 22, 2019/Cancer

Study Validates Clinical Criteria for Very High-Risk Localized Prostate Cancer

Data analyzed from three centers

BackPage 65 of 140Next